Dialyzer Market Is Expected to Reach USD 8.3 Billion by 2030, Grow at a CAGR Of 5.7% during Forecast Period 2023 To 2030 | Data By Contrive Datum Insights Pvt Ltd.
Contrive Datum Insights Pvt Ltd
Contrive Datum Insights Pvt Ltd

According to a market research study published by Contrive Datum Insights, Asia Pacific generated maximum revenue is expected to dominate the market throughout the forecast period.

Farmington, March 30, 2023 (GLOBE NEWSWIRE) -- The Global Dialyzer Market Size Was Valued At USD 2.5 Billion In 2023 And Is Projected To Reach USD 8.3 Billion By 2030, Growing at a CAGR Of 5.7% From 2023 To 2030. A dialyzer is a medical device that takes the place of the kidneys. It does this by using hollow fibers, which are artificial membranes, to remove extra water and waste from the blood. Dialyzers are mostly used by doctors and nurses when they do hemodialysis. Hemodialysis is a medical procedure that takes waste out of the blood of people who have either chronic or sudden kidney failure. Getting rid of waste helps keep the patient's electrolyte balance in check. It also keeps the blood from getting too full of salt and waste, which can make you sick.

Request Sample Copy of Report “Dialyzer Market Size, Share & Trends Estimation Report By Type (Hollow Fiber Dialyzer, Coil Tube Dialyzer, Flat Type Dialyzer), By Application (Dialysis Centers, Hospitals, Home Healthcare), By End-User (Home Healthcare, In-Centers Dialysis), By Region, And Segment Forecasts, 2022 - 2030”, published by Contrive Datum Insights.

Key Developments:

  • In April 2017, JMS Co., Ltd. launched a Mid-term management plan, GAIN 2020 with the aim to increase the productivity of all business segments and to focus strongly on customer-centric business policies

  • In February 2018, Toray Medical Company Limited launched TORAY FILTRYZER NF series dialyzers in Europe market. The new dialyzer serves improved anti-thrombogenicity.

  • In November 2018, Nipro Corporation announced the launch of new advanced single-use dialyzer, CTA (Cellentia-H cellulose triacetate) with the aim to provide improved blood filtration along with a reduction in adverse reactions.

 Regional Outlook:

Asia Pacific made the most money ($3,359.0 Mn) in 2018 and is expected to continue to do so for the next few years. Higher use of hemodialysis to treat end-stage renal disease, which is common, and faster growth of infrastructure, which makes it easier to install hemodialysis machines in developing countries, are expected to drive the growth of the dialyzer market in Asia-Pacific from 2018 to 2026. During the forecast period, North America is expected to bring in the second most money after Asia. Also, Europe had a large share of the global market because there were more people with end-stage renal disease and more people were using hemodialysis. Middle East and Africa and Latin America are also expected to see a lot of growth because their infrastructure is growing quickly and well-known companies are moving into their markets.